Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2868 (LINC02868), also known as C1orf137, is a member of the lincRNA family, which are non-coding RNAs transcribed from regions between protein-coding genes and are longer than 200 nucleotides. LincRNAs, including LINC02868, do not encode proteins but can regulate the expression of neighboring or distant genes through various mechanisms, such as scaffolding proteins for chromatin modification, modulating transcription, or stabilizing target mRNAs. While lincRNAs as a class are increasingly recognized as having roles in fine-tuning gene expression, regulating chromatin structure, and as potential epigenetic regulators, there is currently no specific information linking LINC02868 to particular diseases, therapeutic drug targets, or use as a biomarker.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2868 (LINC02868).